Nichole C. Sanders, Ph.D.
Affiliations: | University of Arkansas for Medical Sciences, United States |
Area:
Behavioral pharmacologyGoogle:
"Nichole Sanders"Mean distance: 17.96 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Galen Wenger | grad student | 2007 | UAMS | |
| (Effects of cognitive enhancers on learning and attention in the Ts65Dn mouse, a model of Down syndrome.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mancino MJ, McGaugh J, Chopra MP, et al. (2014) Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. Journal of Clinical Psychopharmacology. 34: 234-9 |
| Sanders NC, Mancino MJ, Gentry WB, et al. (2013) Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Experimental and Clinical Psychopharmacology. 21: 294-302 |
| Atkinson TS, Sanders N, Mancino M, et al. (2013) Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. Journal of Addiction Medicine. 7: 243-8 |
| Oliveto A, Mancino M, Sanders N, et al. (2013) Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. European Journal of Pharmacology. 715: 424-35 |